Loading…
Avience Biomedicals (AVIENCE)₹249.95−2.00%Medical Equipment & Supplies
Avience Biomedicals is compared with the 10 closest in size in Medical Equipment & Supplies (27 companies in the industry). It has a P/E of 11.5 against a peer median of 22.5, and ROCE of 26.6% against a peer median of 15.0%, and latest-quarter sales growth of 4.9% against a peer median of 1.2%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Medical Equipment & Supplies
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Prevest Denpro | 501 | 23.2 | 24.0 | 17.7 | 0.00 | 0.2 | 72 | 20 | 20.9 | 27.8 | vs AVIENCE |
| QMS Medical Allied Services | 329 | 30.4 | 13.0 | 10.3 | 0.66 | 0.3 | 174 | 12 | 22.2 | 25.4 | vs AVIENCE |
| Nureca | 287 | 60.4 | 3.0 | 1.1 | 0.04 | 0.0 | 147 | 2 | 55.0 | 11.6 | vs AVIENCE |
| Aprameya Engineering | 251 | 49.4 | 12.7 | 7.6 | 0.10 | 0.0 | 55 | 5 | −89.7 | −109.2 | vs AVIENCE |
| Earkart | 153 | 30.9 | 17.4 | 11.7 | 0.00 | 0.0 | 54 | 5 | — | — | vs AVIENCE |
| Vaidya Sane Ayurved Laboratories | 148 | 16.5 | 15.0 | 12.0 | 0.03 | 0.0 | 107 | 9 | 18.8 | 33.2 | vs AVIENCE |
| Avience Biomedicals | 137 | 11.5 | 26.6 | 32.3 | 0.91 | 0.0 | 53 | 9 | 4.9 | −1.4 | — |
| Choksi Asia | 116 | 21.7 | 18.5 | 14.6 | 0.05 | 0.0 | 49 | 5 | −2.4 | 5.7 | vs AVIENCE |
| Shree Pacetronix | 66 | 19.9 | 23.4 | 19.7 | 0.15 | 0.0 | 22 | 3 | −8.1 | 15.4 | vs AVIENCE |
| Mohini Health & Hygiene | 51 | — | −4.0 | −8.9 | 0.39 | 0.0 | 144 | −17 | −6.5 | −1,388.1 | vs AVIENCE |
| Amkay Products | 48 | 20.7 | 12.7 | 9.1 | 0.15 | 0.0 | 42 | 2 | −7.4 | −77.0 | vs AVIENCE |
| Peer median | 148 | 22.5 | 15.0 | 11.7 | 0.10 | 0.0 | 55 | 5 | 1.2 | 8.7 |
Listed companies closest to Avience Biomedicals in Medical Equipment & Supplies include Prevest Denpro, QMS Medical Allied Services, Nureca, Aprameya Engineering, Earkart, Vaidya Sane Ayurved Laboratories, Choksi Asia, Shree Pacetronix.
Prevest Denpro, with a market cap of ₹501 Cr.
Avience Biomedicals trades at a P/E of 11.5; the median of its peer set is 22.5. A P/E above or below the median is a description, not a judgement on value.
Avience Biomedicals' return on capital employed is 26.6%, above the peer median of 15.0%.